As of Nov 25
| +0.27 / +3.66%|
The 4 analysts offering 12-month price forecasts for Syneron Medical Ltd have a median target of 12.50, with a high estimate of 14.00 and a low estimate of 9.40. The median estimate represents a +63.61% increase from the last price of 7.64.
The current consensus among 4 polled investment analysts is to Buy stock in Syneron Medical Ltd. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.